Tag: pediatric drug studies

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image Intranasal Corticosteroids vs Antihistamines: Which is Better for Allergy Relief?
recent-post-image Ayurslim (Himalaya): Safe Use, Ingredients, Side Effects, and Where to Buy in 2025
recent-post-image Diabetes and Weight Loss: Proven Strategies to Manage Blood Sugar and Lose Weight Safely
recent-post-image OTC to Prescription Switches: Safety Considerations for Consumers
recent-post-image Adverse Event Monitoring for Biosimilars: How Safety Surveillance Keeps Patients Protected

Menu

© 2026. All rights reserved.